Evidence map›Paper›PMID 40652122›Full record

ArticleJournal of natural medicines2025

Apoptosis-inducing activity of a steroidal glycoside from Allium chinense G. Don. bulbs in human small-cell lung cancer cells via mitochondrial dysfunction and ER stress.

Tamami Shimazaki, Tomoki Iguchi, Aki Kanda, Ami Shirakawa, Yoshihiro Mimaki

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tamami ShimazakiDepartment of Medicinal Pharmacognosy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Tomoki IguchiDepartment of Medicinal Pharmacognosy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan. iguchit@toyaku.ac.jp.ORCID http://orcid.org/0000-0003-0337-9776
Aki KandaDepartment of Medicinal Pharmacognosy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Ami ShirakawaDepartment of Medicinal Pharmacognosy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Yoshihiro MimakiDepartment of Medicinal Pharmacognosy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.

Funding

Japan Society for the Promotion of Science JP22K15306
6 · The paper itself

Abstract

A saponin fraction from Allium chinense G. Don. bulbs has previously been reported to exhibit cytotoxicity against melanoma and carcinoma cell lines; however, the active compounds responsible for this cytotoxicity have not been identified. A phytochemical investigation was conducted on A. chinense bulbs to identify novel anticancer seeds from natural products. Seven steroidal glycosides (1-7), comprising three spirostan-type (1-3) and four furostan-type (4-7), were obtained. This is the first report of the isolation of 6 and 7 from A. chinese. The cytotoxicity of 1-7 was evaluated in SBC-3 human small-cell lung cancer cells using the MTT assay. Compounds 2, 3, and 5 demonstrated moderate cytotoxicity against SBC-3 cells, with IC

Indexed as

AlliumAntineoplastic Agents, PhytogenicApoptosisEndoplasmic Reticulum StressGlycosidesLung NeoplasmsMitochondriaSmall Cell Lung CarcinomaSteroidsCell Line, TumorHumansOnionsPlant ExtractsPlant RootsReactive Oxygen SpeciesSaponinsAntineoplastic Agents, PhytogenicGlycosidesPlant ExtractsReactive Oxygen SpeciesSaponinsSteroidsAllium chinenseApoptosisEndoplasmic reticulumMitochondriaSBC-3 cellsSteroidal glycoside

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.